Valeant Tumbles on Revenue Outlookt; Bon-Ton, Veritiv Decline

Mukesh Buch
15 Mar, 2016
New York City

Bon-Ton net plunged 29%. Children''s Place profit rose. DSW net tumbled 62% but revenues jumped. FactSet net soared 10%. Valeant Pharma tumbled after lowering revenues forecast. Veritiv net swung to profit while revenues declined 8%.

[R]12:00 PM New York – Bon-Ton net plunged 29%. Children''s Place profit rose. DSW net tumbled 62% but revenues jumped. FactSet net soared 10%. Valeant Pharma tumbled after lowering revenues forecast. Veritiv net swung to profit while revenues declined 8%.[/R]

Tollbooth Index fell 29.75 or 0.3% to 10,541.44.

Earnings Review

The Bon-Ton Stores, Inc ((BONT)) plummeted 9.9% or 26 cents to $2.35 after the department store operator reported net sales in the fourth-quarter ending in January slid 1.3% from a year ago to $950.4 million.

Comparable store sales in the quarter dropped 1.9%.

Net income in the quarter plunged 29.4% to $50.6 million or $2.42 per diluted share compared to $71.7 million or $3.55 per share from the same quarter last year.

The Children''s Place, Inc ((PLCE)) surged 5.9% or $4.21 to $74.89 after the specialty apparel retailer said net sales in the fourth-quarter ending in January jumped 4% from a year ago to $498.5 million.

Comparable store sales in the quarter soared 6.7%.

Net income in the quarter rose 2.9% to $17.5 million or 87 cents per diluted share compared to $17 million or 79 cents per share from the same quarter last year.

In the first-quarter, the retailer estimated net income per diluted share between $1 and $1.06 and in the fiscal 2016, net income per diluted share in the range of $4 to $4.10.

DSW Inc ((DSW)) gained 1.8% or 49 cents to $27.98 after the footwear and accessories retailer stated sales in the fourth-quarter ending in January increased 5% from a year ago to $672 million.

Comparable store sales in the quarter rose 0.7%.

Net income in the quarter tumbled 62% to $11.8 million or 14 cents per diluted share compared to $30.8 million or 34 cents per share from the same quarter last year.

The company forecasted revenues in the fiscal year to increase between 8% and 10% and comparable sales to grow in the range of 1% to 2% and diluted earnings per share to jump in the range of $1.54 to $1.64.

FactSet Research Systems Inc ((FDS)) slumped 3.3% or $5.30 to $149.53 after the financial information provider reported revenues in the fourth-quarter ending in February soared 13.7% from a year ago to $281.8 million.

Net income in the quarter jumped 10.1% to $67.8 million or $1.63 per diluted share compared to $61.6 million or $1.46 per share from the same quarter last year.

The company forecasted revenues in the third-quarter between $286 million and $289 million and diluted earnings per share in the range of $1.54 and $1.58.

Valeant Pharmaceuticals Intl Inc ((VRX)) tumbled 46.4% or $32.05 to $37 after the Canada-focused specialty pharmaceutical company lowered revenue forecast in fiscal 2016 between $11 billion and $11.2 billion from earlier estimated range between $11 billion and $11.2 billion.

As of September 30, Valeant had long-term debt of about $30 billion and said it would repay this year of about $1.7 billion less than the earlier forecast of $2.25 billion.

Veritiv Corp ((VRTV)) plunged 8% or $2.83 to $32.50 after the print, publishing, packaging and logistics solution provider said revenues in the fourth-quarter ending in December declined 7.5% from a year ago to $2.2 billion.

Net in the quarter swung to profit $10.1 million or 63 cents per diluted share compared to a loss of $14 million or 88 cent per share from the same quarter last year.